Freakonomics Radio is a weekly podcast that is adapted for broadcast on public radio stations around the U.S. (check your local station’s schedule). If you heard our show on the radio and want to hear it again, or read a transcript of the original podcast episode, you can find your way to all of that in this archive. And if your public-radio station doesn’t carry Freakonomics Radio, give them a friendly nudge!
In a wide-ranging conversation with Ezekiel Emanuel, the policymaking physician and medical gadfly, we discuss the massive effects of GLP-1 drugs like Ozempic, Wegovy, and Mounjaro. We also talk about the state of cancer care, mysteries in the gut microbiome, flaws in the U.S. healthcare system — and what a second Trump term means for healthcare policy.
John J. Sullivan, a former State Department official and U.S. ambassador, says: “Our politicians aren’t leading — Republicans or Democrats.” He gives a firsthand account of a fateful Biden-Putin encounter, talks about his new book Midnight in Moscow, and predicts what a second Trump term means for Russia, Ukraine, China — and the U.S.
After a dramatic election, Donald Trump has returned from exile. We hear what to expect at home and abroad — and what to do if you didn’t vote for Trump.
Macy’s wants to recapture its glorious past. The author of the Wimpy Kid books wants to rebuild his dilapidated hometown. We just want to listen in. (Part two of a two-part series.)
The 166-year-old chain Macy’s, which is fighting extinction, calls the parade its “gift to the nation.” With 30 million TV viewers, it’s also a big moneymaker. At least we think it is — Macy’s is famously tight-lipped about parade economics. We try to loosen them up. (Part one of a two-part series.)
Chris Weld worked for years in emergency rooms, then ditched that career and bought an old farm in Massachusetts. He set up a distillery and started making prize-winning spirits. When cannabis was legalized, he jumped into that too — and the first few years were lucrative. But now? It turns out that growing, processing, and selling weed is more complicated than it looks. He gave us the grand tour. (Part three of a series.)
Cannabis is booming, so why isn’t anyone getting rich? There are a lot of reasons, including heavy regulations, high taxes, and competition from illegal weed shops. Most operators are losing money and waiting for Washington to get out of the way. In the meantime, it’s not that easy being green. (Part two of a series.)
We have always been a nation of drinkers — but now there are more daily users of cannabis than alcohol. Considering alcohol’s harms, maybe that’s a good thing. But some people worry that the legalization of cannabis has outpaced the research. (Part one of a series.)
Are betting markets more accurate than polls? What kind of chaos would a second Trump term bring? And is U.S. democracy really in danger, or just “sputtering on”?
Sixty percent of the jobs that Americans do today didn’t exist in 1940. What happens as our labor becomes more technical and less physical? And what kinds of jobs will exist in the future?
What happened when the Rooney Rule made its way from pro football to corporate America? Some progress, some backsliding, and a lot of controversy. (Second in a two-part series.)
The biggest sports league in history had a problem: While most of its players were Black, almost none of its head coaches were. So the N.F.L. launched a hiring policy called the Rooney Rule. In the first episode of a two-part series, we look at how the rule succeeded — until it failed.
Young people have been reporting a sharp rise in anxiety and depression. This maps neatly onto the global rise of the smartphone. Some researchers are convinced that one is causing the other. But how strong is the evidence?
Only a tiny number of “supertaskers” are capable of doing two things at once. The rest of us are just making ourselves miserable, and less productive. How can we put the — hang on a second, I’ve just got to get this.
Educators and economists tell us all the reasons college enrollment has been dropping, especially for men, and how to stop the bleeding. (Part 3 of our series from 2022, “Freakonomics Radio Goes Back to School.”)
America’s top colleges are facing record demand. So why don’t they increase supply? (Part 2 of our series from 2022, “Freakonomics Radio Goes Back to School.”)
We think of them as intellectual enclaves and the surest route to a better life. But U.S. colleges also operate like firms, trying to differentiate their products to win market share and prestige points. In the first episode of a special series originally published in 2022, we ask what our chaotic system gets right — and wrong. (Part 1 of “Freakonomics Radio Goes Back to School.”)
Tania Tetlow, a former federal prosecutor and now the president of Fordham University, thinks the modern campus could use a dose of old-fashioned values.
The world’s most valuable unused resource isn’t oil or water or plutonium — it’s human hours. We’ve got an idea for putting them to use, and for building a more human-centered economy. But we need your help.
Is overconsolidation a threat to democracy? That’s the worry. Even the humble eyeglass industry is dominated by a single firm. We look into the global spike in myopia, how the Lemtosh got its name, and what your eye doctor knows that you don’t. (Part two of a two-part series.)
A single company, EssilorLuxottica, owns so much of the eyewear industry that it’s hard to escape their gravitational pull — or their “obscene” markups. Should regulators do something? Can Warby Parker steal market share? And how did Ray-Bans become a luxury brand? (Part one of a two-part series.)
Daniel Kahneman left his mark on academia (and the real world) in countless ways. A group of his friends and colleagues recently gathered in Chicago to reflect on this legacy — and we were there, with microphones.
American politics is trapped in a duopoly, with two all-powerful parties colluding to stifle competition. We revisit a 2018 episode to explain how the political industry works, and talk to a reformer (and former presidential candidate) who is pushing for change.
It’s hard to know whether the benefits of hiring a celebrity are worth the risk. We dig into one gruesome story of an endorsement gone wrong, and find a surprising result.
Every December, a British man named Tom Whitwell publishes a list of 52 things he’s learned that year. These fascinating facts reveal the spectrum of human behavior, from fraud and hypocrisy to Whitwell’s steadfast belief in progress. Should we also believe?
Broadway operates on a winner-take-most business model. A runaway hit like Stereophonic — which just won five Tony Awards — will create a few big winners. But even the stars of the show will have to go elsewhere to make real money. (Part two of a two-part series.)
Hit by Covid, runaway costs, and a zillion streams of competition, serious theater is in serious trouble. A new hit play called Stereophonic — the most Tony-nominated play in history — has something to say about that. We speak with the people who make it happen every night. (Part one of a two-part series.)
Thanks to legal settlements with drug makers and distributors, states have plenty of money to boost prevention and treatment. Will it work? (Part two of a two-part series.)
Most epidemics flare up, do their damage, and fade away. The opioid epidemic has been raging for almost 30 years. To find out why, it’s time to ask some uncomfortable questions. (Part one of a two-part series.)
The economist and social critic Glenn Loury has led a remarkably turbulent life, both professionally and personally. In a new memoir, he has chosen to reveal just about everything. Why?
You want to listen to Freakonomics Radio? That’s great! Most people use a podcast app on their smartphone. It’s free (with the purchase of a phone, of course). Looking for more guidance? We’ve got you covered.
Stay up-to-date on all our shows. We promise no spam.
